LNZTA3WT4
Resource Report
Resource Website
1+ mentions
Discontinued
|
ATCC Cat# CRL-11543, RRID:CVCL_3540
|
Homo sapiens (Human)
|
Astrocytoma
|
Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16., Characteristics: The expression of the luciferase reporter gene as well as the TP53 gene are under the control of a tetO operator., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:27397505 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Male |
LNZTA3p53WT4, WT4 |
ATCC |
CRL-11543 |
CLO:CLO_0007371, ArrayExpress:E-MTAB-3610, ATCC:CRL-11543, BioGRID_ORCS_Cell_line:931, BioSample:SAMN03471340, cancercelllines:CVCL_3540, Cell_Model_Passport:SIDM01220, Cosmic:1995487, Cosmic-CLP:1240170, DepMap:ACH-002269, EGA:EGAS00001000978, GDSC:1240170, GEO:GSM1670052, LINCS_HMS:50028, LINCS_LDP:LCL-1345, PharmacoDB:LNZTA3WT4_853_2019, PRIDE:PXD030304, Wikidata:Q54902866 |
cvcl_0394 |
|
CVCL_3540 |
2026-08-29 05:16:39 |
1 |
NK-92MI
Resource Report
Resource Website
10+ mentions
Possibly Discontinued Discontinued
|
KCB Cat# KCB 200677YJ, RRID:CVCL_3755
|
Homo sapiens (Human)
|
Natural killer cell lymphoblastic leukemia/lymphoma
|
Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers of NK-92MI. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support., Characteristics: No longer dependent on IL2., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:10365666 PMID:27397505 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
NK-92 MI, NK-92 mi, NK92-MI, NK92MI, NK-92 transfected with MFG-hIL2 |
KCB |
KCB 200677YJ |
CLO:CLO_0008178, ATCC:CRL-2408, BCRC:60438, cancercelllines:CVCL_3755, CCRID:1102HUM-NIFDC00065, Cell_Model_Passport:SIDM01201, Cosmic-CLP:1330981, DepMap:ACH-002289, GDSC:1330981, GEO:GSM1670278, KCB:KCB 200677YJ, LINCS_LDP:LCL-1127, PharmacoDB:NK92MI_1160_2019, PRIDE:PXD030304, Wikidata:Q54930658 |
cvcl_2142 |
|
CVCL_3755 |
2026-08-29 05:16:53 |
24 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Ubigene Cat# YC-A012, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Ubigene |
YC-A012 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-08-29 05:16:08 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
BEI_Resources Cat# ARP-153, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
BEI_Resources |
ARP-153 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-08-29 05:16:11 |
39236 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
CCTCC Cat# GDC0152, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
CCTCC |
GDC0152 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:13 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
KCLB Cat# 22190, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
KCLB |
22190 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:13 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
ATCC Cat# CRL-2190, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
ATCC |
CRL-2190 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:11 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
Ubigene Cat# YC-C140, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
Ubigene |
YC-C140 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:11 |
1900 |
AGS
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0139
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Virology: Persistently infected with parainfluenza virus type 5 (PIV5) strain PIV5-AGS (PubMed=17509637; PubMed=27445371)., Population: Caucasian., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: FGFR genetic alteration cell panel (ATCC TCP-1034)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1370612 PMID:6678861 PMID:6831414 PMID:10402490 PMID:15767549 PMID:17509637 PMID:18804159 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24807215 PMID:25485619 PMID:25960936 PMID:25984343 PMID:26589293 PMID:27397505 PMID:27445371 PMID:28196595 PMID:29435981 PMID:29717028 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34466148 PMID:35122114 PMID:35839778
|
Cancer cell line
|
Female |
|
|
|
BTO:BTO_0001007, CLO:CLO_0001686, EFO:EFO_0002109, MCCL:MCC:0000032, CLDB:cl258, CLDB:cl5134, AddexBio:C0023004/4958, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1739, BCRC:60102, BCRJ:0311, BioGRID_ORCS_Cell_line:332, BioSample:SAMN03471028, BioSample:SAMN03471416, BioSample:SAMN10988305, cancercelllines:CVCL_0139, CCRID:1101HUM-PUMC000480, CCRID:3101HUMTCHu232, CCRID:4201HUM-CCTCC00247, CCTCC:GDC0247, Cell_Model_Passport:SIDM00850, ChEMBL-Cells:CHEMBL3308078, ChEMBL-Targets:CHEMBL613860, CLS:300408, Cosmic:685586, Cosmic:848149, Cosmic:868235, Cosmic:873708, Cosmic:887255, Cosmic:888819, Cosmic:906790, Cosmic:1067211, Cosmic:1090463, Cosmic:1187266, Cosmic:1294957, Cosmic:1482073, Cosmic:1518239, Cosmic:1582429, Cosmic:1627261, Cosmic:1995340, Cosmic:2036659, Cosmic:2069770, Cosmic:2484954, Cosmic:2823227, Cosmic-CLP:906790, DepMap:ACH-000880, ECACC:89090402, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:906790, GEO:GSM267417, GEO:GSM267424, GEO:GSM267431, GEO:GSM267438, GEO:GSM552354, GEO:GSM562392, GEO:GSM618009, GEO:GSM618010, GEO:GSM618011, GEO:GSM618012, GEO:GSM827400, GEO:GSM828792, GEO:GSM843440, GEO:GSM886864, GEO:GSM887929, GEO:GSM1237672, GEO:GSM1237697, GEO:GSM1250894, GEO:GSM1250895, GEO:GSM1250896, GEO:GSM1250897, GEO:GSM1374389, GEO:GSM1374390, GEO:GSM1669595, GEO:GSM2983073, GEO:GSM2983074, GEO:GSM2983075, GEO:GSM2983076, IARC_TP53:21171, IBRC:C10071, IGRhCellID:AGS, IZSLER:BS TCL 135, KCB:KCB 200708YJ, KCLB:21739, LiGeA:CCLE_280, LINCS_HMS:50004, LINCS_LDP:LCL-1893, Lonza:727, NCBI_Iran:C131, PharmacoDB:AGS_56_2019, PRIDE:PXD000722, PRIDE:PXD030304, Progenetix:CVCL_0139, PubChem_Cell_line:CVCL_0139, TOKU-E:522, Ubigene:YC-C003, Wikidata:Q54748713 |
|
|
CVCL_0139 |
2026-08-29 05:22:22 |
143 |
AMO1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1806
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine., Characteristics: Produces IgA kappa., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8426482 PMID:9738977 PMID:10936422 PMID:11429052 PMID:12886255 PMID:15215163 PMID:17171682 PMID:18700954 PMID:19306352 PMID:21173094 PMID:22460905 PMID:25485619 PMID:25688540 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30285677 PMID:30545397 PMID:30894373 PMID:31068700 PMID:32123307 PMID:35839778
|
Cancer cell line
|
Female |
AMo1, AMO-1 |
|
|
CLO:CLO_0037047, EFO:EFO_0006534, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-1088, BioSample:SAMN03472930, BioSample:SAMN03473529, BioSample:SAMN10989573, cancercelllines:CVCL_1806, CCRID:1101HUM-PUMC000683, Cell_Model_Passport:SIDM00993, CGH-DB:9156-4, ChEMBL-Cells:CHEMBL4523527, ChEMBL-Targets:CHEMBL4523558, Cosmic:1483074, Cosmic:1889514, Cosmic:2131561, Cosmic:2391800, Cosmic:2809758, Cosmic-CLP:1295741, DepMap:ACH-000838, DSMZ:ACC-538, DSMZCellDive:ACC-538, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1295741, GEO:GSM143353, GEO:GSM290285, GEO:GSM562822, GEO:GSM886868, GEO:GSM887933, GEO:GSM1374392, GEO:GSM1669599, IARC_TP53:28503, IBRC:C10685, LiGeA:CCLE_604, LINCS_LDP:LCL-1539, PharmacoDB:AMO1_62_2019, PRIDE:PXD030304, Progenetix:CVCL_1806, PubChem_Cell_line:CVCL_1806, Wikidata:Q54749810 |
|
|
CVCL_1806 |
2026-08-29 05:22:30 |
15 |
BPH-1
Resource Report
Resource Website
100+ mentions
|
DSMZ Cat# ACC-143, RRID:CVCL_1091
|
Homo sapiens (Human)
|
Benign prostatic hyperplasia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7535634 PMID:11304728 PMID:11719443 PMID:20164919 PMID:20215515 PMID:21248069 PMID:27397505 PMID:30894373 PMID:35839778
|
Transformed cell line
|
Male |
BPH1, Benign Prostatic Hyperplasia-1 |
DSMZ |
ACC-143 |
BTO:BTO_0001323, CLO:CLO_0002022, EFO:EFO_0022691, CLDB:cl7219, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473417, cancercelllines:CVCL_1091, Cell_Model_Passport:SIDM00964, ChEMBL-Cells:CHEMBL3308186, ChEMBL-Targets:CHEMBL2366131, Cosmic:924105, Cosmic:1995347, Cosmic-CLP:924105, DepMap:ACH-001453, DSMZ:ACC-143, DSMZCellDive:ACC-143, EGA:EGAS00001000978, GDSC:924105, GEO:GSM827571, GEO:GSM1374405, GEO:GSM1669628, IARC_TP53:27687, ICLC:HTL11006, IGRhCellID:BPH1, LINCS_HMS:50005, LINCS_LDP:LCL-2095, Millipore:SCC256, PharmacoDB:BPH1_107_2019, PRIDE:PXD030304, Progenetix:CVCL_1091, PubChem_Cell_line:CVCL_1091, SKY/M-FISH/CGH:1510, Wikidata:Q54798059 |
|
|
CVCL_1091 |
2026-08-29 05:26:49 |
169 |
BPH-1
Resource Report
Resource Website
100+ mentions
|
ICLC Cat# HTL11006, RRID:CVCL_1091
|
Homo sapiens (Human)
|
Benign prostatic hyperplasia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7535634 PMID:11304728 PMID:11719443 PMID:20164919 PMID:20215515 PMID:21248069 PMID:27397505 PMID:30894373 PMID:35839778
|
Transformed cell line
|
Male |
BPH1, Benign Prostatic Hyperplasia-1 |
ICLC |
HTL11006 |
BTO:BTO_0001323, CLO:CLO_0002022, EFO:EFO_0022691, CLDB:cl7219, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473417, cancercelllines:CVCL_1091, Cell_Model_Passport:SIDM00964, ChEMBL-Cells:CHEMBL3308186, ChEMBL-Targets:CHEMBL2366131, Cosmic:924105, Cosmic:1995347, Cosmic-CLP:924105, DepMap:ACH-001453, DSMZ:ACC-143, DSMZCellDive:ACC-143, EGA:EGAS00001000978, GDSC:924105, GEO:GSM827571, GEO:GSM1374405, GEO:GSM1669628, IARC_TP53:27687, ICLC:HTL11006, IGRhCellID:BPH1, LINCS_HMS:50005, LINCS_LDP:LCL-2095, Millipore:SCC256, PharmacoDB:BPH1_107_2019, PRIDE:PXD030304, Progenetix:CVCL_1091, PubChem_Cell_line:CVCL_1091, SKY/M-FISH/CGH:1510, Wikidata:Q54798059 |
|
|
CVCL_1091 |
2026-08-29 05:26:49 |
169 |
BALL-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1075
|
Homo sapiens (Human)
|
Adult B acute lymphoblastic leukemia
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:195075 PMID:197412 PMID:2985879 PMID:3159941 PMID:3874327 PMID:6582512 PMID:8139288 PMID:8156010 PMID:8957066 PMID:9290701 PMID:9510473 PMID:15901131 PMID:20164919 PMID:20215515 PMID:27397505 PMID:28196595 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
Ball-1, Ball 1, BALL1, B-cell Acute Lymphoblastic Leukemia-1 |
|
|
BTO:BTO_0001148, CLO:CLO_0037300, CLO:CLO_0051004, CLO:CLO_0051005, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03471059, BioSample:SAMN03472350, cancercelllines:CVCL_1075, CCRID:5301HUM-KCB94007YJ, Cell_Model_Passport:SIDM00287, ChEMBL-Cells:CHEMBL3308839, ChEMBL-Targets:CHEMBL2366269, CLS:305084, Cosmic:910705, Cosmic:919134, Cosmic:999755, Cosmic:999762, Cosmic:1150902, Cosmic-CLP:910705, DepMap:ACH-002211, DSMZ:ACC-742, DSMZCellDive:ACC-742, EGA:EGAS00001000978, FANTOM5_SSTAR:10455-106G5, GDSC:910705, GEO:GSM827223, GEO:GSM1669606, IARC_TP53:21184, JCRB:JCRB0071, KCB:KCB 94007YJ, LINCS_LDP:LCL-1005, PharmacoDB:BALL1_73_2019, PRIDE:PXD030304, Progenetix:CVCL_1075, PubChem_Cell_line:CVCL_1075, RCB:RCB0256, RCB:RCB1882, TKG:TKG 0467, Wikidata:Q54753112 |
|
|
CVCL_1075 |
2026-08-29 05:23:13 |
2 |
Ishikawa (Heraklio) 02 ER-
Resource Report
Resource Website
Possibly Discontinued
|
ECACC Cat# 98032302, RRID:CVCL_6543
|
Homo sapiens (Human)
|
Type I endometrial adenocarcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Probably misclassified/misidentified. ECACC has discontinued this cell line because it displays STR profile from HEC-50B cells (CVCL_2929)..
|
PMID:20215515 PMID:22460905 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
Ishikawa(Heraklio)02ER-, ISHIKAWAHERAKLIO02ER, ER-02 ISH |
ECACC |
98032302 |
CLO:CLO_0006967, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN10988025, cancercelllines:CVCL_6543, Cell_Model_Passport:SIDM00037, ECACC:98032302, EGA:EGAS00001000978, GDSC:1240156, GEO:GSM827371, GEO:GSM887164, GEO:GSM888236, IARC_TP53:28398, LiGeA:CCLE_241, LINCS_HMS:50019, LINCS_LDP:LCL-1498, PharmacoDB:Ishikawa_Heraklio_02ER_668_2019, Progenetix:CVCL_6543, Wikidata:Q54898302 |
cvcl_2529 |
|
CVCL_6543 |
2026-08-29 05:29:12 |
0 |
BB65-RCC
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1078
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10074909 PMID:14762065 PMID:15585611 PMID:18698046 PMID:20164919 PMID:22892449 PMID:27397505 PMID:28489074 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
BB65 RCC, BB65RCC, BB65, CAJE |
|
|
CLO:CLO_0009975, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, cancercelllines:CVCL_1078, Cell_Model_Passport:SIDM00191, ChEMBL-Cells:CHEMBL3308283, ChEMBL-Targets:CHEMBL2366247, Cosmic:753533, Cosmic-CLP:753533, DepMap:ACH-002090, EGA:EGAS00001000978, GDSC:753533, GEO:GSM1669609, IARC_TP53:21188, IARC_TP53:26919, LINCS_LDP:LCL-1763, PharmacoDB:BB65RCC_76_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1078, Wikidata:Q54795073 |
|
|
CVCL_1078 |
2026-08-29 05:26:17 |
1 |
BB49-HNC
Resource Report
Resource Website
|
RRID:CVCL_1077
|
Homo sapiens (Human)
|
Floor of mouth squamous cell carcinoma
|
Population: Caucasian., From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9271594 PMID:11751535 PMID:20164919 PMID:27397505 PMID:30894373
|
Cancer cell line
|
Female |
BB49 HNC, BB49HNC, BB49-SCCHN |
|
|
CLO:CLO_0009940, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, cancercelllines:CVCL_1077, Cell_Model_Passport:SIDM00174, ChEMBL-Cells:CHEMBL3308282, ChEMBL-Targets:CHEMBL2366295, Cosmic:753532, Cosmic:2116768, Cosmic-CLP:753532, DepMap:ACH-002213, EGA:EGAS00001000978, GDSC:753532, GEO:GSM1669608, IARC_TP53:21187, LINCS_LDP:LCL-1574, PharmacoDB:BB49HNC_75_2019, PubChem_Cell_line:CVCL_1077, Wikidata:Q54795063 |
|
|
CVCL_1077 |
2026-08-29 05:26:16 |
0 |
BB30-HNC
Resource Report
Resource Website
|
RRID:CVCL_1076
|
Homo sapiens (Human)
|
Head and neck squamous cell carcinoma
|
Population: Caucasian., From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:27397505 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Female |
BB30 HNC, BB30HNC, BB30-SCCHN |
|
|
CLO:CLO_0009939, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:832, cancercelllines:CVCL_1076, Cell_Model_Passport:SIDM00172, ChEMBL-Cells:CHEMBL3308548, ChEMBL-Targets:CHEMBL2366271, Cosmic:753531, Cosmic:1995343, Cosmic-CLP:753531, DepMap:ACH-002212, EGA:EGAS00001000978, GDSC:753531, GEO:GSM1669607, IARC_TP53:21186, LINCS_LDP:LCL-1573, PharmacoDB:BB30HNC_74_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1076, Wikidata:Q54795061 |
|
|
CVCL_1076 |
2026-08-29 05:26:16 |
0 |
BC-3C
Resource Report
Resource Website
|
RRID:CVCL_1958
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9794224 PMID:22460905 PMID:24035680 PMID:24367658 PMID:29732388 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
BC3c |
|
|
CLO:CLO_0001893, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:506, BioSample:SAMN03473550, BioSample:SAMN10988581, cancercelllines:CVCL_1958, Cell_Model_Passport:SIDM01523, Cosmic:1046690, Cosmic:1285112, Cosmic:1286004, Cosmic:2050437, Cosmic:2057442, Cosmic:2444240, Cosmic:2685938, DepMap:ACH-000593, DSMZ:ACC-450, DSMZCellDive:ACC-450, GEO:GSM886873, GEO:GSM887938, IARC_TP53:30018, LiGeA:CCLE_276, PharmacoDB:BC3C_80_2019, Progenetix:CVCL_1958, Wikidata:Q54795193 |
|
|
CVCL_1958 |
2026-08-29 05:26:17 |
0 |
BDCM
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_4613
|
Homo sapiens (Human)
|
Acute myeloid leukemia
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:12437665 PMID:20215515 PMID:22460905 PMID:30285677 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Male |
B-cell with DC Morphology |
|
|
CLO:CLO_0001910, EFO:EFO_0002113, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:CRL-2740, BioSample:SAMN03471781, BioSample:SAMN10988332, cancercelllines:CVCL_4613, Cell_Model_Passport:SIDM01522, DepMap:ACH-000080, GEO:GSM886876, GEO:GSM887941, IARC_TP53:30019, IGRhCellID:BDCM, LiGeA:CCLE_759, LINCS_LDP:LCL-1049, PharmacoDB:BDCM_83_2019, Progenetix:CVCL_4613, Wikidata:Q54795803 |
|
|
CVCL_4613 |
2026-08-29 05:26:22 |
1 |
AsPC-1
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0152
|
Homo sapiens (Human)
|
Pancreatic ductal adenocarcinoma
|
Caution: TP53 mutation indicated incorrectly as being at c.818G>A in PubMed=1630814., Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1630814 PMID:1764370 PMID:4023565 PMID:6582512 PMID:7182348 PMID:7972006 PMID:8026879 PMID:8194712 PMID:8286197 PMID:9331070 PMID:9665481 PMID:10027410 PMID:10408907 PMID:11115575 PMID:11169959 PMID:11787853 PMID:12692724 PMID:14695172 PMID:15126341 PMID:15367885 PMID:15688027 PMID:15770730 PMID:16912165 PMID:18298655 PMID:18380791 PMID:20037478 PMID:20164919 PMID:20215515 PMID:20418756 PMID:21607521 PMID:22460905 PMID:22585861 PMID:25167228 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26216984 PMID:26586397 PMID:26589293 PMID:27259358 PMID:27397505 PMID:27910856 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:32782605 PMID:35839778
|
Cancer cell line
|
Female |
AsPc-1, Aspc-1, ASPC-1, As-PC1, ASPC1, AsPC1, Aspc1, AsPc1 |
|
|
BTO:BTO_0001864, CLO:CLO_0001756, EFO:EFO_0002112, MCCL:MCC:0000044, CLDB:cl289, AddexBio:C0018023/5061, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1682, BCRC:60494, BioGRID_ORCS_Cell_line:259, BioSample:SAMN03471961, BioSample:SAMN10988235, cancercelllines:CVCL_0152, CCRID:1101HUM-PUMC000214, CCRID:3101HUMTCHu8, Cell_Model_Passport:SIDM00899, CGH-DB:160-1, CGH-DB:9271-4, ChEMBL-Cells:CHEMBL3307994, ChEMBL-Targets:CHEMBL612588, CLS:300158, Cosmic:707247, Cosmic:710851, Cosmic:724645, Cosmic:808166, Cosmic:868239, Cosmic:872994, Cosmic:910702, Cosmic:913308, Cosmic:918050, Cosmic:922255, Cosmic:923164, Cosmic:932514, Cosmic:933515, Cosmic:947398, Cosmic:948371, Cosmic:948740, Cosmic:949230, Cosmic:1006364, Cosmic:1090374, Cosmic:1108341, Cosmic:1198210, Cosmic:1320465, Cosmic:1366285, Cosmic:1477433, Cosmic:1571783, Cosmic:1644318, Cosmic:1995341, Cosmic:2434085, Cosmic:2668289, Cosmic-CLP:910702, DepMap:ACH-000222, ECACC:96020930, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910702, GEO:GSM206446, GEO:GSM383935, GEO:GSM495808, GEO:GSM621911, GEO:GSM784702, GEO:GSM886870, GEO:GSM887935, GEO:GSM1024396, GEO:GSM1177959, GEO:GSM1177960, GEO:GSM1177961, GEO:GSM1374394, GEO:GSM1374395, GEO:GSM1374396, GEO:GSM1588607, GEO:GSM1588619, GEO:GSM1669603, GEO:GSM1906985, GEO:GSM1906986, GEO:GSM1906987, IARC_TP53:311, IARC_TP53:21127, IBRC:C10154, IGRhCellID:AsPC1, IZSLER:BS TCL 171, KCLB:21682, LiGeA:CCLE_008, LINCS_LDP:LCL-1730, NCBI_Iran:C558, PharmacoDB:AsPC1_67_2019, PRIDE:PXD003198, PRIDE:PXD030304, PRIDE:PXD032263, Progenetix:CVCL_0152, PubChem_Cell_line:CVCL_0152, SKY/M-FISH/CGH:1997, Wikidata:Q54750736 |
|
|
CVCL_0152 |
2026-08-29 05:22:40 |
894 |